Improving hematopoietic engraftment: Potential role of mesenchymal stromal cell-derived extracellular vesicles

被引：16
作者：
Preciado, Silvia [1 ,2 ,3 ,4 ,5 ]
Muntion, Sandra [1 ,2 ,3 ,4 ,5 ]
Sanchez-Guijo, Fermin [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构：
[1] IBSAL Hosp Univ Salamanca, Area Terapia Celular, Paseo San Vicente 58-182, Salamanca 37007, Spain
[2] IBSAL Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain
[3] Ctr Red Med Regenerat & Terapia Celular Castilla, Salamanca, Spain
[4] RETIC TerCel, Madrid, Spain
[5] ISCIII, CIBERONC, Madrid, Spain
[6] Univ Salamanca, Ctr Invest Canc, Salamanca, Spain
[7] Univ Salamanca, Dept Med, Salamanca, Spain
来源：
STEM CELLS | 2021年 / 39卷 / 01期
关键词：
engraftment; exosomes; extracellular vesicles; graft failure; hematopoietic stem cell transplantation; hematopoietic stem cells; mesenchymal stromal cells; microvesicles; poor graft function; STEM-CELLS; DIFFERENTIATION; EXOSOMES; THERAPY; IRRADIATION; MICRORNAS; SURVIVAL;
D O I：
10.1002/stem.3278
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
The therapeutic effects of mesenchymal stromal cells (MSCs) in graft failure or poor graft function after allogenic hematopoietic stem cell transplantation (HSCT) are currently undergoing clinical evaluation. MSCs exert their functions, at least partially, through the secretion of extracellular vesicles (MSC-EVs). The available information on the biological potential of MSC-EVs to improve hematopoietic function, both in in vitro studies and in reported preclinical models, focusing on the possible mechanisms of these effects are summarized in the current review. The potential advantages of EVs over MSCs are also discussed, as well as the limitations and uncertainties in terms of isolation, characterization, mechanism of action in this setting, and industrial scalability that should be addressed for their potential clinical application.
引用
收藏
页码：26 / 32
页数：7
相关论文
共 65 条
  • [1] Bone Marrow-Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo
    Amarnath, Shoba
    Foley, Jason E.
    Farthing, Don E.
    Gress, Ronald E.
    Laurence, Arian
    Eckhaus, Michael A.
    Metais, Jean-Yves
    Rose, Jeremy J.
    Hakim, Frances T.
    Felizardo, Tania C.
    Cheng, Austin V.
    Robey, Pamela G.
    Stroncek, David E.
    Sabatino, Marianna
    Battiwalla, Minoo
    Ito, Sawa
    Fowler, Daniel H.
    Barrett, Austin J.
    [J]. STEM CELLS, 2015, 33 (04) : 1200 - 1212
  • [2] Human mesenchymal stem cells secrete hyaluronan-coated extracellular vesicles
    Arasu, Uma Thanigai
    Karna, Riikka
    Harkonen, Kai
    Oikari, Sanna
    Koistinen, Arto
    Kroger, Heikki
    Qu, Chengjuan
    Lammi, Mikko J.
    Rilla, Kirsi
    [J]. MATRIX BIOLOGY, 2017, 64 : 54 - 68
  • [3] Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species
    Baglio, Serena Rubina
    Rooijers, Koos
    Koppers-Lalic, Danijela
    Verweij, Frederik J.
    Lanzon, M. Perez
    Zini, Nicoletta
    Naaijkens, Benno
    Perut, Francesca
    Niessen, Hans W. M.
    Baldini, Nicola
    Pegtel, D. Michiel
    [J]. STEM CELL RESEARCH & THERAPY, 2015, 6
  • [4] The Role of Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (MSC-EVs) in Normal and Abnormal Hematopoiesis and Their Therapeutic Potential
    Batsali, Aristea K.
    Georgopoulou, Anthie
    Mavroudi, Irene
    Matheakakis, Angelos
    Pontikoglou, Charalampos G.
    Papadaki, Helen A.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
  • [5] Budoni M, 2013, CELL TRANSPLANT, V22, P369, DOI 10.3727/096368911X582769
  • [6] Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment
    Carrancio, S.
    Romo, C.
    Ramos, T.
    Lopez-Holgado, N.
    Muntion, S.
    Prins, H. J.
    Martens, A. C.
    Brinon, J. G.
    San Miguel, J. F.
    del Canizo, M. C.
    Sanchez-Guijo, F.
    [J]. CELL TRANSPLANTATION, 2013, 22 (07) : 1171 - 1183
  • [7] Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment
    Carrancio, Soraya
    Blanco, Belen
    Romo, Carlos
    Muntion, Sandra
    Lopez-Holgado, Natalia
    Blanco, Juan F.
    Brinon, Jesus G.
    San Miguel, Jesus F.
    Sanchez-Guijo, Fermin M.
    Consuelo del Canizo, M.
    [J]. PLOS ONE, 2011, 6 (10):
  • [8] Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs
    Chen, Tian Sheng
    Arslan, Fatih
    Yin, Yijun
    Tan, Soon Sim
    Lai, Ruenn Chai
    Choo, Andre Boon Hwa
    Padmanabhan, Jayanthi
    Lee, Chuen Neng
    de Kleijn, Dominique P. V.
    Lim, Sai Kiang
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [9] Immunomodulatory effects of mesenchymal stromal cells-derived exosome
    Chen, Wancheng
    Huang, Yukai
    Han, Jiaochan
    Yu, Lili
    Li, Yanli
    Lu, Ziyuan
    Li, Hongbo
    Liu, Zenghui
    Shi, Chenyan
    Duan, Fengqi
    Xiao, Yang
    [J]. IMMUNOLOGIC RESEARCH, 2016, 64 (04) : 831 - 840
  • [10] Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
    Cominal, Jucara Gastaldi
    Cacemiro, Maira da Costa
    Pinto-Simoes, Belinda
    Kolb, Hans-Jochem
    Ribeiro Malmegrim, Kelen Cristina
    de Castro, Fabiola Attie
    [J]. STEM CELLS INTERNATIONAL, 2019, 2019
1234567